Brown Vance R 4

What Happened

• Vance R. Brown, EVP, General Counsel and Corporate Secretary of Boston Scientific (BSX), received a total of 34,416 shares on Feb 13–16, 2026 through a mix of awards/grants and conversion/exercise of derivative awards (reported as code A and M).
• To satisfy tax-withholding obligations related to those awards/exercises (code F), 14,577 shares were surrendered/withheld at $74.73 per share, generating proceeds of $1,089,339. The awards themselves were reported with $0.00 acquisition price (typical for vested performance/RSU conversions).

Key Details

• Transaction dates: Feb 13, 14 and 16, 2026. Filing date: Feb 18, 2026 (filed timely).
• Gross shares acquired: 34,416 (29,608 from awards; 4,808 from conversion/exercise of derivatives).
• Shares disposed for tax payment: 14,577 at $74.73 each, total ~$1,089,339.
• Form codes: A = Award/Grant, M = Exercise/conversion of derivative, F = Payment of exercise price or tax liability (share withholding).
• Shares owned after the transactions: not stated in the filing.
• Notable footnotes:
  • F1–F2: Awards include performance share units granted Feb 14, 2023; performance criteria and service condition were determined satisfied as of Feb 13, 2026.
  • F3: Each restricted stock unit equals one share of common stock.
  • F4–F6: Some shares are to be issued in four equal annual installments beginning on Feb 13, 2026; Feb 14, 2024; and Feb 16, 2023, respectively (per the filing).

Context

• This was primarily the vesting/settlement of performance shares and conversion/exercise of derivative awards, not an open-market buy or discretionary sale. The reported share disposals represent withholding to cover taxes (a routine administrative step), not an independent sale for cash proceeds beyond the tax obligation.
• Derivative entries (code M) reflect conversion/exercise of vested awards into common stock; the related F entries show shares withheld/surrendered to meet tax liabilities.